IAIM
VRDN icon

International Assets Investment Management’s Viridian Therapeutics VRDN Stock Holding History

International Assets Investment Management’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77K Hold
150
– – ﹤0.01% 2081
2026
Q1 		$2.87K Sell
150
-200
-57% -$5.94K ﹤0.01% 1930
2025
Q4 		$10.9K Buy
+350
New +$9.6K ﹤0.01% 1637
2024
Q4 		– Sell
-879
Closed -$20K – 1929
2024
Q3 		$20K Buy
+879
New +$14.4K ﹤0.01% 1376

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

International Assets Investment Management's VRDN Position: Q2 2026 in Review

International Assets Investment Management held its Viridian Therapeutics (VRDN) position steady in Q2 2026 at 150 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

International Assets Investment Management first reported a position in VRDN in Q3 2024 and has held it in 4 quarters since. The position peaked at $20K in Q3 2024. 214 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

  • International Assets Investment Management held 150 shares of Viridian Therapeutics worth $2.77K as of Q2 2026.
  • International Assets Investment Management left its Viridian Therapeutics share count unchanged in Q2 2026.
  • Viridian Therapeutics made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2081 holding.
  • International Assets Investment Management first reported a position in Viridian Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • International Assets Investment Management's Viridian Therapeutics position peaked at $20K in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.